Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Revive also has other products in their pipeline. $RVVTF
Sad that cancer patients are dying but this is good they have another option for pain. And this is good for Revive Therapeutics who make those.@Revive_RVV $rvvtf
— Billy L Degrimes (@DegrimesL) August 4, 2020
Revive is also partnering with Pharm-Olam to help them advance the future clinical study for Bucillamine as a potential treatment for COVID-19 in a U.S. FDA clinical study. $RVVTF
https://www.linkedin.com/organization-guest/company/pharm-olam-llc
https://www.pharm-olam.com/news/pharm-olam-selected-to-support-revive-therapeutics-development-of-bucillamine-for-covid-19
Pharm-Olam selected to support Revive Therapeutics development of Bucillamine for COVID-19
TORONTO, March 25, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases, is pleased to announce that the Company has retained Pharm-Olam, LLC, with proven clinical experience in infectious diseases completing over 100 clinical studies in approximately 19,000 patients at over 2,000 clinical sites, to serve as the Company’s Contract Research Organization (“CRO”) to advance the future clinical study for Bucillamine in the treatment of infectious diseases, including the coronavirus disease (“COVID-19”). In addition, Revive has added Dr. Kelly McKee, Jr., MD, MPH as Chief Scientific Officer consultant and Dr. Onesmo Mpanju, PhD as Regulatory Affairs consultant to the Company’s clinical development team.
“We are very pleased to have Pharm-Olam as our partner in guiding us towards our goal to investigate Bucillamine as a potential treatment for COVID-19 in a U.S. FDA clinical study and in other infectious diseases clinical studies in the future,” said Michael Frank, Chief Executive Officer of Revive. "Pharm-Olam has the proven experience in managing infectious disease clinical studies, a scalable ecosystem for expediting and completing clinical studies on time and on budget, and most importantly they have an infectious disease team of experts with the addition of Dr. McKee and Dr. Mpanju who will develop and oversee Revive’s clinical study and its expeditious submission of our IND with the FDA.”
Dr. McKee is currently Senior Scientific and Medical Advisor for Pharm-Olam. Previously, Dr. McKee served Pharm-Olam’s Chief Medical Officer, and as Vice President, Vaccines and Public Health, in the Infectious Diseases and Vaccines Center of Excellence at IQVIA (previously QuintilesIMS). He brings over 30 years of experience in research and development from the bench to the bedside, with specific expertise in vaccines, emerging diseases, biodefense, respiratory viral infections, and sexually transmitted infections. His progressive clinical research experience began in 1981 at Fort Detrick, Frederick, Md., United States, where he served as a research virologist, immunologist, and Head of the Dept of Clinical Investigation and Medical Division at the US Army Medical Research Institute of Infectious Diseases (USAMRIID).
Dr. Onesmo Mpanju, PhD has over 28 years of experience in biopharmaceutical R&D, including 18 years as a regulatory scientist. Previously, Dr. Mpanju was a Reviewer at the U.S. FDA, Center for Biologics Evaluation & Research. His consulting experience includes non-commercial entities such as the U.S. National Institutes of Health, US Army Medical Materiel Development Activity (USAMMDA), the Bill & Melinda Gates Foundation, and others. Dr. Mpanju holds a Ph.D. in Experimental Medicine (Infectious Diseases) from the University of British Columbia, Vancouver, Canada.
Nice 102,263 share slap @ 0.38. $RVVTF
Nice! Now time for people to start chasing once they un-halt. $RVVTF
That's the answer that we all are waiting for. Looks like the MM's are fishing for stop losses.
It's looking like approval will go through for phase 3. Read between the lines and you may find a diamond in the rough. UPDATED JULY 30TH. LET'S GO! $rvv x $rvvtf pic.twitter.com/CwXMx2x1YP
— TheGatsby (@TheGatsby780) July 30, 2020
A lot of buys coming in. $RVVTF must be close to breaking out of this channel soon.
Wow, thanks for sharing that tweet. Can't wait for tomorrow.
Great job everyone and another good close today. Looking forward to the CC tomorrow.
Yeah, it was getting hit and than they undercut the ask again to protect it. They are trying to accumulate more shares on the bid.
Once CDEL's 1.7 milly @ .0432 gets knocked off the ask we should be testing the HOD again. IMO
I hope CDEL with that 1.7 milly ask @ .0432 gets his shares stolen for trying to re-load more on the bid.
Nice end of day buys and a green close today with low volume. $TPTW
We now just need to get rid of these bid whackers before the next leg up.
Nice buys coming in and pressure is building on anticipation leading up to the this Fridays CC.
Nice update sneaking in a pr this am and I'm looking forward to the CC this Friday. GLTA
Overall a good day here. Slow and steady. Looking forward to the CC this Friday.
I totally understand where your coming from and it's frustrating when the stock has been constantly attacked for the last couple of trading sessions.
What's reassuring is the company didn't hesitate to come out with a pr addressing the fake news and to have a share holders conference call at the end of week to provide clarity as to all areas of corporate development.
That's great to hear that they responding to shareholders.
https://twitter.com/VultradeLLC/status/1285307375813922816
Welcome to the OTC cause it actually happens a lot. I'm glad that TPTW addressed the fake rumor as fast as they did.
That wasn't me that put out that fake tweet. It was circulating on twitter and I just posted it to see if someone else could confirm if it was real.
TPT Global Tech Signs 5G Deal with BT Not True and Company Disclaims Announcement Completely
https://www.accesswire.com/598141/TPT-Global-Tech-Signs-5G-Deal-with-BT-Not-True-and-Company-Disclaims-Announcement-Completely
Monday, July 20, 2020 3:30 PM
SAN DIEGO, CA / ACCESSWIRE / July 20, 2020 / TPT Global Tech, Inc. ("TPTW, the Company or TPT Global Tech") (OTCQB:TPTW) announced today that a false statement was posted on Social Media claiming the company signed a deal with BT for a 5G rollout in the UK. The company is putting out this official statement that the post was false in nature and the company is disclaiming the statement completely.
"We will continue support accurate information into the market. We want our shareholders to know that they should only rely on information from official TPT Global Tech official," said Stephen Thomas, CEO.
About TPT Global Tech
TPT Global Tech Inc. (TPTW) based in San Diego, California, is a technology-based company with divisions providing telecommunications, medical technology and product distribution, media content for domestic and international syndication as well as technology solutions. TPT Global Tech offers Software as a Service (SaaS), Technology Platform as a Service (PAAS), Cloud-based Unified Communication as a Service (UCaaS). It offers carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT's cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media and collaboration features in today's global technology markets. TPT Global Tech also operates as a Master Distributor for Nationwide Mobile Virtual Network Operators (MVNO) and Independent Sales Organization (ISO) as a Master Distributor for Pre-Paid Cellphone services, Mobile phones Cellphone Accessories and Global Roaming Cellphones.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.
Frank Benedetto
619-915-9422
SOURCE: TPT Global Tech, Inc.
According to this tweet the PODS are waiting for temp permit/zoning approval.
https://twitter.com/KikiSoko/status/1285278720203403271
5G UK news. Can someone confirm.
https://twitter.com/AlexTraugott/status/1285277962925940737
Where in Florida and what location?
Ok. Thanks for the update.
Did they imply that they physically have the labs and how many do they have if they are referring to labs as plural? Nothing shows up yet for the Instagram @qklabs.
I think you might be right. I guess we will have to wait and see what the rest of the week has in store. I wouldn't want to be without shares that's for sure. $TPTW
No problem. GLTA $TPTW
I wouldn't either but some are still dumb enough to sell after seeing this live video.. $TPTW
Live video unedited of the Quiklab. $TPTW
$TPTW
— Robert (@_RobertMichael_) July 15, 2020
Ok... i managed to scratch up some actual live video... unedited... of the QuikLab
You're welcome
Yes theyre real... pic.twitter.com/OI6A01HOcz
Image of the QuikLab looks good. $TPTW
$TPTW the new Quiklab is out!!!https://t.co/V66kP8tqMD#Covid #CovidTesting #5G #telemedecine #MobileTesting pic.twitter.com/DLeSeGJr3f
— Robert (@_RobertMichael_) June 18, 2020
They have been talking bad about this company the last week driving the price down. I hope they have to cover at a loss. $GNUS
Hear we go, buckle up folks. $TLSS
Some big buys coming in and bid keeps creeping up. Almost green now. $TLSS
Looking good now and moving on up. Getting closer to going green. $TLSS
50M has traded in over an hour of trading so there is still interest. CFGN is casually sitting at 0.068 on the ask. Lets see if that is any indication where we will finish today, one can hope. $TLSS